Lamivudine prophylaxis in liver transplantation for hepatitis B in Asians

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 535-536

  Lo, C M ^a   Fan, S T ^a   Lai, C L ^b   Liu, C L ^a   Yuen, M F ^b   Ng, I O ^b   Wong, J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; STEROID; TACROLIMUS; VIRUS DNA;

ASIAN; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; REINFECTION;

ANTIVIRAL AGENTS; ASIA; DNA, VIRAL; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HONG KONG; HUMANS; LAMIVUDINE; LIVER TRANSPLANTATION; RECURRENCE; SURVIVAL RATE; TIME FACTORS;

EID: 0032986360     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01542-5     Document Type: Conference Paper

References (4)

1. Jurim O., Martin P., Shaked A., et al. Transplantation. 57:1994;1393.
2. Muller R., Samuel D., Fassati L., et al. J Hepatol. 21:1994;1140.
3. Grellier L., Mutimer D., Ahmed M., et al. Lancet. 348:1996;1212.
4. Bartholomew M., Jansen R., Jeffers L., et al. Lancet. 349:1997;20.